Evaluation of POLE/POLD1 variants as potential biomarkers for immune checkpoint inhibitor treatment outcomes Correspondence

  

Authors:	Rousseau, B.; Vidal, J.; Diaz, L. A. Jr
Title:	Evaluation of POLE/POLD1 variants as potential biomarkers for immune checkpoint inhibitor treatment outcomes
Keywords:	treatment outcome; unclassified drug; overall survival; somatic mutation; letter; gene; microsatellite instability; mutation rate; immune checkpoint inhibitor; human; pole gene; antineoplastic monoclonal antibody; tumor mutation burden; pold1 gene
Journal Title:	JAMA Oncology
Volume:	6
Issue:	4
ISSN:	2374-2437
Publisher:	American Medical Association
Date Published:	2020-04-01
Start Page:	589
End Page:	590
Language:	English
DOI:	10.1001/jamaoncol.2020.0065
PUBMED:	32134429
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081545881&doi=10.1001%2fjamaoncol.2020.0065&partnerID=40&md5=ad80aa666f217bf2254b05dd7867dfbd
Notes:	Letter -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/166089